Across TCGA pan-cancer cohorts, CST13P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CST13P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CST13P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CST13P is over-expressed in tumor.

BRCA and HNSC are the cancer types where CST13P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CST13P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.020	.001	4	view →
HNSC	Male	All	+0.015	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CST13P RNA expression & survival · all CST13P data types